Stay updated with breaking news from Mass Spec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
908 Devices (NASDAQ:MASS – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.04, Briefing.com reports. The company had revenue of $12.09 million during the quarter, compared to analyst estimates of $10.39 million. 908 Devices had […]
Dr. Sushmita 'Mimi' Roy is a distinguished scientist and biotechnology expert known for her significant contributions in chemistry, biochemistry, and analytical sciences. With a diverse career in academia, industry, entrepreneurship, and leadership, Roy specializes in proteomics, metabolomics, and biologics.
908 Devices (NASDAQ:MASS – Free Report) and Polarean Imaging (OTCMKTS:PLLWF – Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Insider and Institutional Ownership 68.2% of 908 Devices shares are […]
Integration of Polymer Standards Service Ltd. products results in the most complete and versatile GPC/SEC portfolio on the market ... | June 12, 2023
Nikko Asset Management Americas Inc. decreased its stake in shares of 908 Devices Inc. (NASDAQ:MASS – Get Rating) by 6.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 559,120 shares of the company’s stock after selling 36,761 shares during the period. Nikko Asset Management […]